Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biotage Launches ACI™ - Accelerated Chromatographic Isolation

Published: Monday, June 30, 2014
Last Updated: Monday, June 30, 2014
Bookmark and Share
Biotage announces the launch of ACI™ (Accelerated Chromatographic Isolation), a new advance converting simple flash purification into a faster and more economical way to isolate pure compounds.

Biotage believes that ACI™ will radically improve the efficiency of the laboratory, embracing the latest developments in purification technology to guide chemists towards improved chromatography. With running costs a concern in most laboratories, ACI™ will efficiently move users to the end-point even faster. Traditional purification taking more than 15 minutes is reduced to 5 minutes; a 250 mg scale laboratory scale experiment can now be purified in less than 3 minutes on a 10 g column with an ACI™ enabled Biotage Isolera™ flash purification system.

“This is a very exciting and pivotal development, the speed enhancements are akin to the impact felt when microwaves first hit the scene. There is nothing out there that comes close to this system. Chemists will now have freedom to work on other things while they let their ACI™ system do the purification. It is fully automated, reliable and lightning fast, we can completely purify 250 mg of sample in less than 3 minutes, this is quicker than most people take to run the TLC” says Dr Sunil Rana, Global Product Manager, Biotage.

Biotage Isolera™ systems already recommend cartridges based on the sample size and programmed TLC data; they work out the best solvent gradient based on compound, and provide real time indication of eluting compounds, using UV, ELSD or Mass Detection. They subtract signal baselines automatically, so chemists can be confident that the correct fractions are collected. 

ACI™ radically improves this, working seamlessly with the Biotage Isolera™ system, the simple wizard quickly guides chemists through the system, beneficial for new users or those whose expertise or priorities lie in synthesis rather than purification. Existing Biotage Isolera systems can be upgraded to ACI™ systems, and ACI™ will come as standard on all new production systems.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biotage and Peptide Synthesis
CEM claim to won a “patent dispute” with Biotage.
Tuesday, May 14, 2013
New Methods for the Extraction of Key Compounds for Clinical, Environmental and Forensic Applications
A new series of application notes utilizing the industry-standard RapidTrace® SPE Workstation for medicinal and analytical chemistry have been released.
Monday, January 10, 2011
Peptide Synthesis Webinar Series Introduces Second Installment: Synthesis of Difficult Peptide Sequences
Biotage announces the second installment in its series of webinars focusing on peptide synthesis.
Friday, October 29, 2010
Peptide Synthesis Webinar Series Introduces Second Installment: Synthesis of Difficult Peptide Sequences
Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, announced the second installment in its series of webinars focusing on peptide synthesis.
Wednesday, October 27, 2010
Biotage Announces Research Collaboration with University of Copenhagen for Peptide Synthesis
Collaborations aims to develop new applications on the Biotage Syro Wave in the field of synthetic peptide and protein chemistry.
Thursday, May 13, 2010
Biotage Awarded Patent for Flash Purification Method Development and Optimization
The Company has been awarded U.S. patent 7686959: Control system and Method for Flash Separation.
Wednesday, April 21, 2010
Biotage Introduces EVOLUTE WCX: Now Providing a Total Solution for Basic Compounds
Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, today announced the further expansion of its successful family of products with the launch of Evolute WCX.
Wednesday, March 17, 2010
Biotage Joins Forces with MultiSynTech and Enters the Peptide Synthesis Business
Biotage enters agreements concerning both the distribution rights for MultiSynTechs systems and the establishment of a joint development project.
Tuesday, February 24, 2009
Biotage Makes a Change in Top Management after Business Area President Resigns
David Patteson, President of the business area Discovery Chemistry will leave the company on 1 April 2006.
Tuesday, February 28, 2006
Biotage Receives its Largest Order to Date
Instruments, which originate from the recently acquired company Argonaut, will be used by chemists to enhance the processes used in the development of pharmaceuticals.
Friday, August 12, 2005
Biotage expands European presence

Wednesday, April 09, 2003
ProcessDevelopment.net welcomes Biotage UK, Ltd.

Tuesday, February 18, 2003
Scientific News
Health Risks of Saturated Fats Aggravated by Immune Response
Research shows that the presence of saturated fats resulted in monocytes migrating into the tissues of vital organs.
Changing the Biological Data Visualisation World
Scientists at TGAC, alongside European partners, have created a cutting-edge, open source community for the life sciences.
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!